Skip to content

Drug interactions

Erlotinib + Siponimod

Severity: Minor

Erlotinib and Siponimod: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Erlotinib is not significantly myelosuppressive but can cause skin toxicity and rash that predispose to infection. Combined with siponimod-induced lymphopenia, infection risk may be slightly increased.

What this interaction means in plain words

Erlotinib and Siponimod have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Erlotinib belongs to Oncology; Siponimod belongs to Central Nervous System.

Evidence level: Low

Why it happens

Weak additive effects on infection susceptibility: siponimod lowers lymphocytes and EGFR inhibition disrupts skin barrier function.

What to do

Routine monitoring for infection is sufficient. Check lymphocyte counts per siponimod labeling.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Erlotinib and Siponimod, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Erlotinib with Siponimod?

MediHelp rates the interaction as minor. Erlotinib and Siponimod have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Erlotinib is not significantly myelosuppressive but can cause skin toxicity and rash that predispose to infection. Combined with siponimod-induced lymphopenia, infection risk may be slightly increased.

How serious is the interaction between Erlotinib and Siponimod?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Routine monitoring for infection is sufficient. Check lymphocyte counts per siponimod labeling.

What other medicines interact with Siponimod?

MediHelp also lists interactions of Siponimod with, for example, Cladribine, Fingolimod, Fluconazole. The full list is on the Siponimod page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in